Closure Medical (CLSR) fomerly Tri-Point Medical (TPMC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Closure Medical (CLSR) fomerly Tri-Point Medical (TPMC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James A. Solis who wrote ()	9/21/1997 4:16:00 PM
From: Saban Kurucay	of 184

While there is a good story behind this stock is clearly way overvalued at this point. They are loosing money at an accelerated pace. If they get FDA approval for their new product which is likely, they probably could benefit next year. But still not clear, because it takes money to market, distribute and sell a new product, too. Then, let's say they make a huge amount of money next year.. let's say .50/share. This is unlikely to happen but even with this kind of an exagerrated earnings the stock would still have a P/E of 68 based on the current jprice. Just my .02 worth.... --Saban

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next